Literature DB >> 2450466

Tumor-promoting phorbol esters induce angiogenesis in vivo.

P B Morris1, T Hida, P J Blackshear, G K Klintworth, J L Swain.   

Abstract

It has been hypothesized that tumor growth is dependent on the concomitant growth of its vascular supply, and thus agents that stimulate angiogenesis may help support tumor growth. Phorbol esters are potent tumor promoters that induce a variety of biochemical effects in cells, including activation of protein kinase C. The specific mechanisms responsible for tumor promotion by phorbol esters are unknown. The objective of this study was to determine whether the tumor-promoting phorbol esters can induce vascular growth. Phorbol esters were tested for their ability to stimulate angiogenesis in vivo using the chick chorioallantoic membrane and rabbit cornea assays. The active tumor promoters 12-O-tetradecanoyl phorbol-13-acetate and phorbol 12,13-didecanoate, which activate protein kinase C, were found to stimulate angiogenesis in a dose-dependent manner. In contrast, 4 alpha-phorbol 12,13-didecanoate, which is inactive as a tumor promoter and does not activate protein kinase C, did not stimulate angiogenesis. Phorbol esters may be indirect angiogenic factors, since no mitogenic effect on bovine capillary endothelial cells in culture could be detected. The results demonstrate that the tumor-promoting activity of phorbol esters may, in part, be secondary to stimulation of neovascularization to support tumor growth and suggest a role for the activation of protein kinase C in this process.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450466     DOI: 10.1152/ajpcell.1988.254.2.C318

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Subtypes of protein kinase C in rat cerebral microvessels.

Authors:  H Kobayashi; T Mizuki; Y Koda; M Okazaki; A Kuroiwa; F Izumi
Journal:  Experientia       Date:  1991-03-15

3.  Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells.

Authors:  M A Hull; J L Thomson; C J Hawkey
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

4.  VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting.

Authors:  Sunday Oladipupo; Song Hu; Joanna Kovalski; Junjie Yao; Andrea Santeford; Rebecca E Sohn; Ralph Shohet; Konstantin Maslov; Lihong V Wang; Jeffrey M Arbeit
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-22       Impact factor: 11.205

Review 5.  Tumor angiogenesis: the pivotal role of vascular endothelial growth factor.

Authors:  D Marmé
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.

Authors:  R Hanemaaijer; P Koolwijk; L le Clercq; W J de Vree; V W van Hinsbergh
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

7.  Formation of endothelial lumens requires a coordinated PKCepsilon-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation.

Authors:  Wonshill Koh; Kamakshi Sachidanandam; Amber N Stratman; Anastasia Sacharidou; Anne M Mayo; Eric A Murphy; David A Cheresh; George E Davis
Journal:  J Cell Sci       Date:  2009-05-12       Impact factor: 5.285

8.  Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat.

Authors:  D E Hu; T P Fan
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

9.  Glycosaminoglycans enhance phorbol ester-induced proteolytic activity and angiogenesis in vitro.

Authors:  D Y Wang; C H Kao; V C Yang; J K Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

10.  A unique protein kinase C-dependent pathway for tissue factor downregulation in pericytes.

Authors:  Laura J Sommerville; Kristen L Gorman; Stacey A Snyder; Dougald M Monroe; Maureane Hoffman
Journal:  J Thromb Haemost       Date:  2019-03-01       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.